Journey Medical (DERM) Short term Debt (2021 - 2025)
Historic Short term Debt for Journey Medical (DERM) over the last 4 years, with Q3 2025 value amounting to $5.6 million.
- Journey Medical's Short term Debt changed N/A to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year change of. This contributed to the annual value of $2.9 million for FY2022, which is 26305.42% up from last year.
- Per Journey Medical's latest filing, its Short term Debt stood at $5.6 million for Q3 2025.
- Over the past 5 years, Journey Medical's Short term Debt peaked at $9.9 million during Q2 2023, and registered a low of $812000.0 during Q4 2021.
- For the 4-year period, Journey Medical's Short term Debt averaged around $5.0 million, with its median value being $3.8 million (2025).
- The largest annual percentage gain for Journey Medical's Short term Debt in the last 5 years was 26305.42% (2022), contrasted with its biggest fall of 26305.42% (2022).
- Journey Medical's Short term Debt (Quarter) stood at $812000.0 in 2021, then soared by 263.05% to $2.9 million in 2022, then surged by 237.25% to $9.9 million in 2023, then tumbled by 43.42% to $5.6 million in 2025.
- Its last three reported values are $5.6 million in Q3 2025, $3.8 million for Q2 2025, and $1.9 million during Q1 2025.